Adimab LLC 13D and 13G filings for Invivyd, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-22 4:15 pm Sale | 2024-01-19 | 13D | Invivyd, Inc. IVVD | Adimab LLC | 21,687,906 19.700% | -5,000,000 (-18.74%) | Filing |
| 2022-06-24 4:54 pm Unchanged | 2022-06-22 | 13D | Invivyd, Inc. IVVD | Adimab LLC | 26,687,906 24.300% | 0 (Unchanged) | Filing |
| 2022-04-25 8:11 pm Unchanged | 2022-04-25 | 13D | Invivyd, Inc. IVVD | Adimab LLC | 26,687,906 24.300% | 0 (Unchanged) | Filing |
| 2022-03-30 4:21 pm Purchase | 2022-03-28 | 13D | Invivyd, Inc. IVVD | Adimab LLC | 26,687,906 24.000% | 26,687,906 (New Position) | Filing |